NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/05/2023
Back to search
Official data from USPTO
ADVZ
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
09/05/2023
Trademark type
Word
Nice classes
5
Filing date
04/01/2022
Registration date
09/05/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/05/2023
Last transaction
09/05/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
03
Owner location
London, GB
Examiner
SUE, ABIGAIL
Law office
M80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Mercury Pharma Group Limited
Representatives
Meghna Prasad BAKER BOTTS L.L.P.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
A full line of pharmaceuticals for the treatment of depressionhypertensionmalariametastatic prostate cancerbenign prostatic hyperplasiapartial seizures in adults with epilepsyattention deficit hyperactivity disorder (ADHD)heart failure in adultsheart failure in pediatric patientsatrial fibrillation in adultsedema associated with congestive heart failureedema associated with cirrhosis of the liveredema associated with nephrotic syndromesteroid-induced edemaidiopathic edemaedema due to secondary hyperaldosteronismacute enterocolitisduodenal ulcerirritable bowel syndrome being irritable colonspastic colonmucous colitis; anti-inflammatory medicinesimmunosuppressive agentscorticosteroids; pharmaceutical preparations for the treatment of cancers and abnormal cells; all of the foregoing excluding pharmaceutical preparations acting on the peripheral or central nervous systemsurgical kits comprised of medical and surgical apparatus and instrumentssurgical implants comprised of human and animal tissue; all of the foregoing excluding anti-infective pharmaceutical preparations and excluding over the counter analgesic products or pain relief products
Publications
History of USPTO decisions and trademark events.
25 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
09/05/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/20/2023
PUBO
PUBLISHED FOR OPPOSITION
06/20/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/31/2023
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
05/15/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/08/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
05/05/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/05/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
05/05/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/05/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/04/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/04/2023
ALIE
ASSIGNED TO LIE
05/04/2023
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
02/02/2023
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
01/24/2023
GNSL
LETTER OF SUSPENSION E-MAILED
01/24/2023
CNSL
SUSPENSION LETTER WRITTEN
01/24/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
01/24/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/24/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
01/24/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/24/2023
DOCK
ASSIGNED TO EXAMINER
01/18/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/06/2022
NWAP
NEW APPLICATION ENTERED
04/05/2022
Continuous trademark protection
Get notified about every new filing that threatens ADVZ or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.